-
Je něco špatně v tomto záznamu ?
Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation
K. Kluckova, M. Sticha, J. Cerny, T. Mracek, L. Dong, Z. Drahota, E. Gottlieb, J. Neuzil, J. Rohlena,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
Freely Accessible Science Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
ProQuest Central
od 2010-01-01 do 2017-12-31
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
Health & Medicine (ProQuest)
od 2010-01-01 do 2017-12-31
ROAD: Directory of Open Access Scholarly Resources
od 2010
Springer Nature OA/Free Journals
od 2010-01-01
Springer Nature - nature.com Journals - Fully Open Access
od 2010-01-01
PubMed
25950479
DOI
10.1038/cddis.2015.110
Knihovny.cz E-zdroje
- MeSH
- buněčná smrt fyziologie MeSH
- konformace proteinů MeSH
- lidé MeSH
- mitochondrie metabolismus fyziologie MeSH
- molekulární sekvence - údaje MeSH
- mutageneze cílená MeSH
- respirační komplex II chemie genetika metabolismus fyziologie MeSH
- sekvence aminokyselin MeSH
- ubichinon chemie genetika metabolismus MeSH
- vazebná místa MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.
Faculty of Sciences Charles University Prague Czech Republic
Institute of Biotechnology Academy of Sciences of the Czech Republic Prague Czech Republic
Institute of Physiology Academy of Sciences of the Czech Republic Prague Czech Republic
School of Medical Science Griffith University Southport Queensland Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010225
- 003
- CZ-PrNML
- 005
- 20240314091310.0
- 007
- ta
- 008
- 160408e20150507enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/cddis.2015.110 $2 doi
- 024 7_
- $a 10.1038/cddis.2015.110 $2 doi
- 035 __
- $a (PubMed)25950479
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kluckova, K $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 245 10
- $a Ubiquinone-binding site mutagenesis reveals the role of mitochondrial complex II in cell death initiation / $c K. Kluckova, M. Sticha, J. Cerny, T. Mracek, L. Dong, Z. Drahota, E. Gottlieb, J. Neuzil, J. Rohlena,
- 520 9_
- $a Respiratory complex II (CII, succinate dehydrogenase, SDH) inhibition can induce cell death, but the mechanistic details need clarification. To elucidate the role of reactive oxygen species (ROS) formation upon the ubiquinone-binding (Qp) site blockade, we substituted CII subunit C (SDHC) residues lining the Qp site by site-directed mutagenesis. Cell lines carrying these mutations were characterized on the bases of CII activity and exposed to Qp site inhibitors MitoVES, thenoyltrifluoroacetone (TTFA) and Atpenin A5. We found that I56F and S68A SDHC variants, which support succinate-mediated respiration and maintain low intracellular succinate, were less efficiently inhibited by MitoVES than the wild-type (WT) variant. Importantly, associated ROS generation and cell death induction was also impaired, and cell death in the WT cells was malonate and catalase sensitive. In contrast, the S68A variant was much more susceptible to TTFA inhibition than the I56F variant or the WT CII, which was again reflected by enhanced ROS formation and increased malonate- and catalase-sensitive cell death induction. The R72C variant that accumulates intracellular succinate due to compromised CII activity was resistant to MitoVES and TTFA treatment and did not increase ROS, even though TTFA efficiently generated ROS at low succinate in mitochondria isolated from R72C cells. Similarly, the high-affinity Qp site inhibitor Atpenin A5 rapidly increased intracellular succinate in WT cells but did not induce ROS or cell death, unlike MitoVES and TTFA that upregulated succinate only moderately. These results demonstrate that cell death initiation upon CII inhibition depends on ROS and that the extent of cell death correlates with the potency of inhibition at the Qp site unless intracellular succinate is high. In addition, this validates the Qp site of CII as a target for cell death induction with relevance to cancer therapy.
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a vazebná místa $7 D001665
- 650 _2
- $a buněčná smrt $x fyziologie $7 D016923
- 650 _2
- $a respirační komplex II $x chemie $x genetika $x metabolismus $x fyziologie $7 D042963
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $x fyziologie $7 D008928
- 650 _2
- $a molekulární sekvence - údaje $7 D008969
- 650 _2
- $a mutageneze cílená $7 D016297
- 650 _2
- $a konformace proteinů $7 D011487
- 650 _2
- $a ubichinon $x chemie $x genetika $x metabolismus $7 D014451
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sticha, M $u Faculty of Sciences, Charles University, Prague, Czech Republic.
- 700 1_
- $a Cerny, J $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Mracek, T $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 700 1_
- $a Dong, L $u School of Medical Science, Griffith University, Southport, Queensland, Australia.
- 700 1_
- $a Drahota, Zdeněk, $d 1932- $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic. $7 jn20000400531
- 700 1_
- $a Gottlieb, E $u The Beatson Institute for Cancer Research, Glasgow, UK.
- 700 1_
- $a Neuzil, J $u 1] Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic [2] School of Medical Science, Griffith University, Southport, Queensland, Australia.
- 700 1_
- $a Rohlena, J $u Institute of Biotechnology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
- 773 0_
- $w MED00173233 $t Cell death & disease $x 2041-4889 $g Roč. 6 (20150507), s. e1749
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25950479 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20240314091304 $b ABA008
- 999 __
- $a ok $b bmc $g 1113654 $s 934593
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 6 $c - $d e1749 $e 20150507 $i 2041-4889 $m Cell death & disease $n Cell Death Dis $x MED00173233
- LZP __
- $a Pubmed-20160408